Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects
2019
71 citations
Journal Article
bronze Open Access
Field-Weighted Citation Impact:
5.57
Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects | Researchclopedia
Oliver Bautista
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Huaping Tang
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Dai Wang
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
A. Fisher
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Timothy D. Culp
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rituparna Das
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Karen Beck
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Gretchen Tamms
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
Luwy Musey
·
Merck & Co., Inc., Rahway, NJ, USA (United States)
V160-001 Study Group